Neuraxis, INC (NYSE: NRXS)

$7.24 +0.24 (+3.50%)
As of Apr 21, 2026 03:58 PM
Sector: Healthcare Industry: Biotechnology CIK: 0001933567
Market Cap 66.67 Mn
P/E -7.65
P/S 18.68
Div. Yield 0.00
Revenue Growth (1y) (Qtr) 27.19
Add ratio to table...

About

Consolidation Items Breakdown of Revenue (2024)

Indefinite-Lived Intangible Assets Breakdown of Revenue (2024)

Peer comparison

Companies in the Biotechnology
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 VRTX Vertex Pharmaceuticals Inc / Ma 111.34 Bn 28.15 9.28 -
2 REGN Regeneron Pharmaceuticals, Inc. 78.06 Bn 17.30 5.44 1.99 Bn
3 ALNY Alnylam Pharmaceuticals, Inc. 41.92 Bn 152.39 13.31 -
4 RVMD Revolution Medicines, Inc. 28.36 Bn -25.11 34,170.56 -
5 ZLAB Zai Lab Ltd 25.77 Bn -147.06 106.30 0.20 Bn
6 MESO Mesoblast Ltd 24.32 Bn -190.54 1,414.27 0.12 Bn
7 MRNA Moderna, Inc. 21.25 Bn -7.52 10.93 0.59 Bn
8 RPRX Royalty Pharma plc 20.83 Bn 27.08 8.76 8.95 Bn